BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26850201)

  • 1. Prognostic value of ABO blood group in patients with gastric cancer.
    Xu YQ; Jiang TW; Cui YH; Zhao YL; Qiu LQ
    J Surg Res; 2016 Mar; 201(1):188-95. PubMed ID: 26850201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model.
    Deng Q; He B; Liu X; Yue J; Ying H; Pan Y; Sun H; Chen J; Wang F; Gao T; Zhang L; Wang S
    J Transl Med; 2015 Feb; 13():66. PubMed ID: 25885254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting recurrence after curative resection for gastric cancer: External validation of the Italian Research Group for Gastric Cancer (GIRCG) prognostic scoring system.
    Barchi LC; Yagi OK; Jacob CE; Mucerino DR; Ribeiro U; Marrelli D; Roviello F; Cecconello I; Zilberstein B
    Eur J Surg Oncol; 2016 Jan; 42(1):123-31. PubMed ID: 26365755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram.
    Strong VE; Song KY; Park CH; Jacks LM; Gonen M; Shah M; Coit DG; Brennan MF
    Ann Surg; 2010 Apr; 251(4):640-6. PubMed ID: 20224369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a prognostic nomogram for predicting early recurrence after curative resection of stage II/III gastric cancer.
    Ma M; Xiao H; Li L; Yin X; Zhou H; Quan H; Ouyang Y; Huang G; Li X; Xiao H
    World J Surg Oncol; 2019 Dec; 17(1):223. PubMed ID: 31856828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of a gastric cancer nomogram using a cancer registry.
    Ashfaq A; Kidwell JT; McGhan LJ; Dueck AC; Pockaj BA; Gray RJ; Bagaria SP; Wasif N
    J Surg Oncol; 2015 Sep; 112(4):377-80. PubMed ID: 26271201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nomogram to predict overall survival and disease-free survival after curative resection of gastric adenocarcinoma.
    Kim Y; Spolverato G; Ejaz A; Squires MH; Poultsides G; Fields RC; Bloomston M; Weber SM; Votanopoulos K; Acher AW; Jin LX; Hawkins WG; Schmidt C; Kooby D; Worhunsky D; Saunders N; Levine EA; Cho CS; Maithel SK; Pawlik TM
    Ann Surg Oncol; 2015; 22(6):1828-35. PubMed ID: 25388061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on prognosis relationship between ABO blood groups of patients with gastric cancer].
    Xiao S; Feng F; Sun L; Xu G; Lian X; Guo M; Nai C; Liu Z; Liu S; Zhang L; Cai L; Liu J; Zhang H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Oct; 18(10):1011-5. PubMed ID: 26499147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood type AB predicts promising prognosis in gastric cancer patients with positive preoperative serum CEA.
    Xiao S; Feng F; Sun L; Cai L; Liu Z; Liu S; Fan D; Zhang H
    Medicine (Baltimore); 2017 Nov; 96(47):e8496. PubMed ID: 29381925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of preoperative neutrophils to lymphocytes ratio in patients resected for gastric cancer.
    Graziosi L; Marino E; De Angelis V; Rebonato A; Cavazzoni E; Donini A
    Am J Surg; 2015 Feb; 209(2):333-7. PubMed ID: 25190544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognosis of gastric cancer patients with marginally elevated carcinoembryonic antigen (CEA) values after D2 radical gastrectomy.
    Chen S; Feng XY; Li YF; Zhao BW; Zhou ZW; Chen YB
    J Surg Oncol; 2013 May; 107(6):641-5. PubMed ID: 23297055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood transfusion does not affect survival of gastric cancer patients.
    Cui J; Deng J; Ding X; Zhang L; Zhang R; Wu W; Hao X; Liang H
    J Surg Res; 2016 Jan; 200(1):98-104. PubMed ID: 26253454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
    Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
    Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of ABO Blood Groups and Risk of Gastric Cancer.
    Yu H; Xu N; Li ZK; Xia H; Ren HT; Li N; Wei JB; Bao HZ
    Scand J Surg; 2020 Dec; 109(4):309-313. PubMed ID: 31282314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of surgical margin status in gastric cancer patients.
    Liang Y; Ding X; Wang X; Wang B; Deng J; Zhang L; Liang H
    ANZ J Surg; 2015 Sep; 85(9):678-84. PubMed ID: 24438078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of metastatic lymph nodes ratio in patients with gastric adenocarcinoma after curative gastrectomy.
    Zhang M; Wang J; Shi W; Chen W; Li W; Shu Y; Liu P; Lu K
    Chin Med J (Engl); 2014; 127(10):1874-8. PubMed ID: 24824248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor volume as a prognostic factor was superior to the seventh edition of the pT classification in resectable gastric cancer.
    Jiang N; Deng JY; Ding XW; Liu Y; Liang H
    Eur J Surg Oncol; 2015 Mar; 41(3):315-22. PubMed ID: 25601610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A relationship between ABO blood groups and clinicopathologic characteristics of patients with gastric adenocarcinoma in China.
    Qiu MZ; Zhang DS; Ruan DY; Luo HY; Wang ZQ; Zhou ZW; Wang FH; Li YH; Xu RH
    Med Oncol; 2011 Dec; 28 Suppl 1():S268-73. PubMed ID: 21053099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of detecting symptomatic or asymptomatic recurrence in patients with gastric cancer after a curative gastrectomy.
    Bilici A; Salman T; Oven Ustaalioglu BB; Unek T; Seker M; Aliustaoglu M; Gezen C; Unek T; Yavuzer D; Unlu M; Gumus M; Yilmaz U
    J Surg Res; 2013 Mar; 180(1):e1-9. PubMed ID: 22520575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Better outcomes by monitoring tumour dynamics using sensitive tumour markers in patients with recurrent gastric cancer.
    Komatsu S; Ichikawa D; Nishimura Y; Kubota T; Okamoto K; Shiozaki A; Fujiwara H; Konishi H; Murayama Y; Kuriu Y; Ikoma H; Nakanishi M; Otsuji E
    Anticancer Res; 2013 Apr; 33(4):1621-7. PubMed ID: 23564806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.